NantWorks to invest $85.5m in former Pfizer plant
January 16, 2012Manufacturing and Production Exubera, Nantworks, Pfizer
A former Pfizer manufacturing facility in Indiana, US, looks set for a new lease of life after technology company NantWorks …
Molecular Profiles starts work on clinical manufacturing facility
January 16, 2012Manufacturing and Production Molecular Profiles
UK contract research and manufacturing services company Molecular Profiles has announced a £9 million investment in manufacturing facilities in the …
Xoma opts out of in-house manufacturing
January 16, 2012Manufacturing and Production Xoma, manufacturing
US biotech Xoma has decided to rely on a contract manufacturing organisation for its Phase III and commercial production needs, …
Complete Worldwide appoints Andy Turner
January 16, 2012Business Services, Medical Communications, Sales and Marketing Andy Turner, Complete Worldwide
Andy Turner has joined the medical communications firm Complete Worldwide, to head up a new capability they are building in …
Europe wants regulatory reform over PIP implant scandal
January 16, 2012Manufacturing and Production, Sales and Marketing EC, MHRA, PIP implants
The European Commission is seeking regulatory reform for class III medical devices after problems with French-made breast implants. The French …
Covidien appoints Mark Trudeau President of pharmaceuticals segment
January 16, 2012Business Services, Manufacturing and Production, Sales and Marketing Covidien
Covidien has announced the appointment of Mark Trudeau as president of its Pharmaceuticals segment and a senior vice president of the company. …
NICE says yes to Tasigna for resistant disease
January 13, 2012Sales and Marketing BMS, Glivec, NICE, Novartis, Tasigna
NICE is recommending Novartis’ Tasigna for chronic myeloid leukaemia patients that can no longer use Glivec. In final guidance it …
AstraZeneca does data deal
January 13, 2012Sales and Marketing AstraZeneca, IMS Health, data
AstraZeneca has signed a deal with an information company in a bid to improve the data it has on how …
Tracy Baker moves to MSI Consultancy
January 13, 2012Medical Communications MSI Consultancy
MSI Consultancy has appointed former Novartis manager Tracy Baker as a new consultant. Tracy has over seven years of sales …
Novartis to cut 2,000 US jobs
January 13, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Diovan, Novartis, job cuts
Novartis will slash 1,960 jobs in the US as it prepares for life without its blockbuster medicine Diovan. The hypertension …
Pharma unprepared for annus horribilis
January 12, 2012Research and Development, Sales and Marketing AZ, Pfizer, Takeda, patents, pharma
A new survey shows pharma is not prepared to deal with the tough year ahead as many blockbuster drugs begin …
Glide Pharma appoints Dr Ian Smith as its new chief executive
January 12, 2012Business Services, Manufacturing and Production, Sales and Marketing
Glide Pharma, a firm focused on the needle-free administration of solid dose therapeutics and vaccines, has appointed Dr Ian Smith …
NICE rejects Sanofi’s Jevtana
January 12, 2012Sales and Marketing Jevtana, NICE, Sanofi, Zytiga
NICE is not recommending Sanofi’s prostate cancer drug Jevtana due to its high cost and questions over its safety. In …
Merck facility reborn as science park
January 11, 2012Research and Development BioCity, MSD, Merck, Newhouse, Pfizer, Roslin BioCentre, Scotland
A former Merck research site in Scotland has been given a new lease of life as a biotech science park. …
NICE guidance to be enforced, says Lansley
January 11, 2012Sales and Marketing NHS, NICE, PCTs, black lists, prescribing
Local NHS organisations will no longer be allowed to ‘ban’ drugs recommended by NICE, the health secretary has said.England’s primary …
Crisis in the boardroom: 2011’s most dramatic departures
January 11, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actelion, KV pharmaceuticals, Kindler, Pfizer, management
In December 2010, Jeffrey Kindler, the chief executive of Pfizer suddenly announced his departure from the company.His abrupt exit made …
Janssen signs deal with rising star Forma
January 11, 2012Research and Development Forma, Janssen, alliance
Janssen has signed a deal with Forma Therapeutics to discover, and develop drugs that target tumour metabolism mechanisms.Forma focuses on …
Richard Barker joins Aegate as a senior advisor
January 11, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Aegate, Richard Barker
Aegate’s board of directors have announced that the previous director general of the ABPI has joined the company as a …
Sanofi to collaborate with UCSF on diabetes research
January 11, 2012Research and Development RNA interference, Sanofi, UCSF, academic alliance, diabetes
The University of California, San Francisco (UCSF) and Sanofi are to launch a new collaboration in diabetes research, focusing on …
Allergan plans $350m expansion of Irish plant
January 10, 2012Manufacturing and Production Allergan, Ireland
Allergan has announced plans to invest $350 million in an expansion of its manufacturing facility in County Mayo, Ireland, a …
Latest content
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
